Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Feb 2025 for Seres Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Lisa von Moltke: trading record in brief
Filings by Lisa von Moltke span 2 companies, the busiest being Seres Therapeutics, Inc. and Tvardi Therapeutics, Inc. Between 1 June 2023 and 15 February 2025, the trades on record add up to 9 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 19 February 2025: an option exercise, in Seres Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lisa von Moltke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
2,969 sharesCommon StockSEC:0000950170-25-023569:0
2,969 sharesCommon StockSEC:0000950170-24-128626:0
13,744 shares0Common StockSEC:0000950170-24-118424:0
2,969 sharesCommon StockSEC:0000950170-24-098717:0
150,647 shares0Common StockSEC:0001415889-24-015763:0
2,968 sharesCommon StockSEC:0000950170-24-062061:0
11,875 sharesCommon StockSEC:0000950170-24-016690:0
13,745 shares0Common StockSEC:0000899243-23-020070:0
32,362 shares0Common StockSEC:0001209191-23-034341:0
9 of 9 declarations
